"Oncology, it is our new Covid," said Bourla. "We did what we did with Covid. We are very proud to have saved the world but it is behind us now, we want to do once more and I think oncology is our best chance to do it."

Fox Business interviewed Pfizer CEO Albert Bourla Wednesday during a report on the recent bounce-back of their stock price. Bourla discussed reasons why Pfizer is once again profitable, including the pharmaceutical company's expectation to reap massive profits via the sale of cancer drugs in the near future.

"Oncology, it is our new Covid," Bourla said. "We did what we did with Covid. We are very proud to have saved the world but it is behind us now, we want to do once more and I think oncology is our best chance to do it."